Randomized Clinical Trial for Primary Molar Pulpotomy, Biodentine Vs Formocresol-ZOE
NCT ID: NCT02201498
Last Updated: 2018-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2014-09-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biodentine Versus White MTA Pulpotomy
NCT01733420
BiodentineTM Versus Formocresol Pulpotomy Technique in Primary Molars
NCT03779698
Clinical and Radiographic Evaluation of Biodentine Versus Formocresol
NCT03582319
Biodentine Partial Pulpotomy of Pulpally Exposed Primary Molars
NCT02393326
Post Operative Pain of Partial Pulpotomy Using a Bioceramic Material in Patients With Symptomatic Irreversible Pulpitis
NCT05956613
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Formocresol/OZE
Conventional pulpotomy technique, with formocresol and zinc oxide eugenol
Pulpotomies with Formocresol/OZE and Biodentine
Biodentine
New technique, with biodentine
Pulpotomies with Formocresol/OZE and Biodentine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulpotomies with Formocresol/OZE and Biodentine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* less than 1/3 of physiologic root resorption
* asymptomatic tooth (with no history of symptoms)
* no clinical or radiological sign of pathology
* vital tooth, with carious pulpal exposure
* hemostasis must be obtained simply with pressure in less than 5 min
* teeth restored with stainless steel crowns
Exclusion Criteria
* symptomatic tooth (presently or history of symptoms)
* previous pulpal treatment on the tooth
* necrotic pulp
* hyperemic pulp
* inadequate operative technique, defective restauration
* non diagnostic x-ray (pre or post treatment)
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Septodont
INDUSTRY
St. Justine's Hospital
OTHER
Université de Montréal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Sainte-Justine
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIODENT1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.